Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Apr;105(7):1013-21.
doi: 10.1172/JCI8583.

Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor

Affiliations

Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor

T Ueda et al. J Clin Invest. 2000 Apr.

Abstract

Here, we demonstrate a significant ex vivo expansion of human hematopoietic stem cells capable of repopulating in NOD/SCID mice. Using a combination of stem cell factor (SCF), Flk2/Flt3 ligand (FL), thrombopoietin (TPO), and a complex of IL-6 and soluble IL-6 receptor (IL-6/sIL-6R), we cultured cord blood CD34(+) cells for 7 days and transplanted these cells into NOD/SCID mice. Bone marrow engraftment was judged successful when recipient animals contained measurable numbers of human CD45(+) cells 10-12 weeks after transplantation. When cells were cultured with SCF+FL+TPO+IL-6/sIL-6R, 13 of 16 recipients were successfully engrafted, and CD45(+) cells represented 11.5% of bone marrow cells in engrafted recipients. Cells cultured with a subset of these factors were less efficiently engrafted, both as measured by frequency of successful transplantations and prevalence of CD45(+) cells. In animals receiving cells cultured with all 4 factors, human CD45(+) cells represented various lineages, including a large number of CD34(+) cells. The proportion of CD45(+) cells in recipient marrow was 10 times higher in animals receiving these cultured cells than in those receiving comparable numbers of fresh CD34(+) cells, and the expansion rate was estimated at 4.2-fold by a limiting dilution method. Addition of IL-3 to the cytokine combination abrogated the repopulating ability of the expanded cells. The present study may provide a novel culture method for the expansion of human transplantable hematopoietic stem cells suitable for clinical applications.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The expansion of total cells (a) and HPCs (b) by SCF+FL, SCF+FL+TPO, and SCF+FL+TPO+IL-6/sIL-6R. A total of 2 × 104 CB CD34+ cells from 3 samples were cultured, and the numbers of total cells and colony-forming cells in the clonal culture were analyzed at day 7 of culture. AStatistically different from data corresponding to the fresh CB CD34+ cells (P < 0.01, Student’s t test).
Figure 2
Figure 2
The repopulating ability of fresh CB CD34+ cells and the cells cultured with SCF+FL, SCF+FL+TPO, and SCF+FL+TPO+IL-6/sIL-6R. A total of 2 × 104 CB CD34+ cells and their progenies were transplanted into NOD/SCID mice, and the proportion of human CD45+ cells in recipient BM cells was analyzed by flow cytometry 12 weeks after the transplantation.
Figure 3
Figure 3
The expression of CD10, CD19, CD3, CD13, CD33, and CD34 on human CD45+ cells (shown in Figure 2) repopulating in BM of NOD/SCID mice engrafted with fresh CB CD34+ cells and the cells cultured with SCF+FL, SCF+FL+TPO, and SCF+FL+TPO+IL-6/sIL-6R.
Figure 4
Figure 4
The comparison of the proportions of human CD45+ cells in BM cells of NOD/SCID mouse recipients transplanted with fresh CB CD34+ cells from 12 different samples and their progenies cultured with SCF+FL+TPO+IL-6/sIL-6R. NOD/SCID mice were injected with 1 × 104 to 2 × 104 fresh CB CD34+ and their progenies, and the proportions of human CD45+ cells in recipient BM cells were analyzed by flow cytometry 10–12 weeks after the transplantation. The percentages of CD45+ cells in BM cells of the recipients transplanted with the cultured cells were higher than those with fresh CB CD34+ cells (P < 0.01, Mann-Whitney U test). EX, experiment.
Figure 5
Figure 5
The frequencies of human HSCs capable of repopulating in NOD/SCID mice in fresh CB CD34+ cells (n = 52) and the cells cultured with SCF+FL+TPO+IL-6/sIL-6R (n = 38). They were estimated as 1 in 39,386 and 1 in 9,484, respectively, by a limiting dilution method.
Figure 6
Figure 6
The effects of IL-3 on the expansion of total cells (a), HPCs (b), and LTR-HSCs (c). A total of 1 × 104 CB CD34+ cells were cultured with SCF+FL+TPO+IL-6/sIL-6R in the presence or absence of IL-3, and the numbers of total cells and colony-forming cells were analyzed at day 7 of culture. Cells cultured from 6 different samples were also transplanted into NOD/SCID mice (n = 12), and the proportions of human CD45+ cells in recipient BM cells were analyzed by flow cytometry 12 weeks after the transplantation. (c) The effects of the addition of IL-3 on the proportions of CD45+ cells in recipient BM cells in 4 samples whose progenies cultured with SCF+FL+TPO+IL-6/sIL-6R exhibited repopulating ability. The percentages of CD45+ cells in BM cells of the recipients transplanted with the cells cultured with IL-3 were lower than those without IL-3 (P < 0.01, Mann-Whitney U test). EX, experiment.

Comment in

Similar articles

Cited by

References

    1. Williams DE, de Vries P, Namen AE, Widmer MB, Lyman SD. The steel factor. Dev Biol. 1992;151:368–376. - PubMed
    1. Rosnet O, et al. Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood. 1993;82:1110–1119. - PubMed
    1. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell. 1991;65:1143–1152. - PubMed
    1. Small D, et al. STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA. 1994;91:459–463. - PMC - PubMed
    1. Osawa M, et al. In vivo self-renewal of c-Kit+ Sca-1+ Lin(low/–) hemopoietic stem cells. J Immunol. 1996;156:3207–3214. - PubMed

Publication types

MeSH terms